Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Jardiance and Its Alleged Connection to Fournier’s Gangrene

FDA Warning 

In August 2018, the FDA issued a warning regarding a possible link between SGLT2 inhibitors and Fournier’s gangrene. The warning came after the FDA’s analysis of events from 2013-2018 found several cases of Fournier’s gangrene in patients receiving SGLT2 inhibitors, including Jardiance. This warning served as the initial trigger for various legal actions against the manufacturers of these drugs, including Boehringer Ingelheim and Eli Lilly. [1]

Legal Actions and Lawsuits 

Several lawsuits were filed after the FDA warning, primarily focusing on the manufacturers’ alleged failure to properly warn patients and their physicians about the risk of Fournier’s gangrene. Plaintiffs argue that they were not informed about the potential risks and, therefore, could not make a well-informed decision about their treatment. [2]

Latest in the Litigation 

As of recent updates, the litigation process is ongoing. Both sides present robust arguments. The defendants maintain that they had adequately communicated all potential risks through their product labeling and deny any negligence in this matter. [3]

 On the other hand, plaintiffs insist that the potential risk of developing Fournier’s gangrene was not sufficiently explained, arguing that, had they been aware of these risks, they might have opted for alternative treatments. Courts have yet not reached a definitive conclusion. This case can potentially prompt further scrutiny regarding the responsibility of pharma companies in providing comprehensive safety data on their drugs and may set precedence for laws regulating drug safety information disclosure. [3]

If you or a loved one has suffered an injury from Jardiance, give us a call at the Michael Brady Lynch Firm at 888-585-5970 or brandon@mblynchfirm.com. 

Date: August 15, 2023

Author: Brandon Salter

Citations

[1] https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrences-serious-infection-genital-area-sglt2-inhibitors-diabetes

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450557/

[3] https://www.drugs.com/medical-answers/jardiance-perineum-3552698/#:~:text=Jardiance%20has%20a%20rare%20side,anus%20and%20vulva%20in%20women

Injured on a Cruise Ship? Call Us

Injured on a Cruise Ship? Call Us

Cruise vacations promise relaxation and adventure, but accidents do happen. Injuries aboard cruise ships can range from minor incidents to severe accidents, raising complicated legal questions about liability and compensation.

read more
Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

According to the National Center for Biotechnology Medicine, more people die from drug overdoses in the US than any other form of accidental death. Opioid overdoses outnumber the historical peak death rate of HIV, gun violence, and car crashes. There’s no doubt we’re in the middle of an opioid crisis. Often, people become addicted to this drug after a legitimate prescription to manage pain after surgery or a chronic pain condition.

read more
Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Over the past 20 to 30 years, studies and mainstream media outlets have blamed video games for desensitizing minors to violence, increased obesity rates, sedentary lifestyles, and mental health issues like depression and anxiety. Now, developers are facing video game lawsuits from gamers who have become addicted to video games. Learn more about video game addiction and what to do if you or a loved one have suffered from video game addiction below.

read more
Ozempic Lawsuit 2024: The Latest Updates

Ozempic Lawsuit 2024: The Latest Updates

The FDA has approved Ozempic, a medication manufactured by Dutch company Novo Nordisk, for treating type 2 diabetes. Many healthcare providers also prescribe Ozempic to their patients for weight management purposes. This is because the medication’s active ingredient, semaglutide, has been approved for weight loss treatments.

read more
PFAS Lawsuit Update: March 2024

PFAS Lawsuit Update: March 2024

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
×
What Our Clients Are Saying